aod9604 fat loss clinical trial AOD-9604 Peptide AOD-9604: The Fat-Loss Peptide —
Description
These effects limit growth hormones suitability for many individuals, particularly those with metabolic syndrome, diabetes, or cancer concerns
Doses higher than 60mcg/kg of body weight can lead to hGH peaks reaching up to 26.6ng/ml (80mIU/l) [17]
If the deficiency was purely dietary, oral supplementation may be considered after initial repletion
This makes it a potentially safer option for individuals concerned about insulin sensitivity or diabetes risk
